Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Karen L. Smith currently holds 45,000 shares of ANTARES PHARMA, INC. (ATRS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Karen L. Smith has been a net seller of ATRS stock. They have purchased $250.0K and sold $2.9M worth of shares.
Karen L. Smith's most recent insider trade was on Jun 24, 2026, when they sold 45,000 shares at $0.00 per share.
Karen L. Smith serves as Executive at ANTARES PHARMA, INC. (ATRS). They have executed 60 insider transactions totaling $3.1M over their tenure at the company.
Karen L. Smith holds the position of Executive at ANTARES PHARMA, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Karen L. Smith has shown a selling trading pattern, with $250.0K in total purchases and $2.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Karen L. Smith was on Apr 5, 2021, when they sold $1.6M worth of XLRN shares. This transaction involved 11,223 shares at $140.13 per share.
Karen L. Smith currently owns 45,000 shares of ANTARES PHARMA, INC. (ATRS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Karen L. Smith's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Karen L. Smith has 60 Form 4 filings on record as an insider at ANTARES PHARMA, INC..
Set alerts for Karen L. Smith and 40,000+ other insiders.